US2007042467A1PendingUtilityA1
NIMA interacting proteins
Assignee: SALK INST FOR BIOLOGICAL STUDIPriority: Nov 13, 1995Filed: Oct 23, 2006Published: Feb 22, 2007
Est. expiryNov 13, 2015(expired)· nominal 20-yr term from priority
C12N 9/90A61K 38/00C12Y 502/01008
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A novel class of NIMA interacting proteins (PIN), exemplified by Pin1, is provided. Pin1 induces a G2 arrest and delays NIMA-induced mitosis when overexpressed, and triggers mitotic arrest and DNA fragmentation when depleted. Methods of identifying other Pin proteins and Pin-interacting proteins and identifying compositions which affect Pin activity or expression are also provided.
Claims
exact text as granted — not AI-modified1 . A functional fragment of a Pin1 polypeptide, which Pin1 polypeptide consists of the amino acid sequence set forth in SEQ ID NO:2, wherein the functional fragment has peptidyl prolyl isomerase (PPIase) activity and/or NIMA-binding activity.
2 . The functional fragment of claim 1 , wherein the functional fragment has PPIase activity and NIMA-binding activity.
3 . The functional fragment of claim 1 , wherein the functional fragment has PPIase activity.
4 . The functional fragment of claim 3 , wherein the functional fragment is at least 105 residues in length.
5 . The functional fragment of claim 1 , wherein the functional fragment has NIMA-binding activity.
6 . The functional fragment of claim 5 , wherein the functional fragment is at least 39 residues in length.
7 . A Pin1 polypeptide fragment consisting of a conservative variant of:
(a) residues 5-43 of SEQ ID NO:2; or (b) a functional fragment of (a) having NIMA-binding activity; wherein the conservative variant has NIMA-binding activity.
8 . The Pin1 polypeptide fragment of claim 7 , wherein the conservative variant amino acid(s) occur at one or more of residues 5, 6, 9, 13-19, 21, 22, 25, 28, 30, 31, 33, 35, 36, and/or 38-43.
9 . The Pin1 polypeptide fragment of claim 7 , wherein at least residues 7, 8, 10-12, 20, 23, 24, 26, 27, 29, 32, 34, and 37 of the conservative variant are the identical to the corresponding residue in SEQ ID NO:2.
10 . A Pin1 polypeptide consisting of a conservative variant of:
(a) residues 59-163 of SEQ ID NO:2; or (b) a functional fragment of (a) having PPIase activity; wherein the conservative variant has PPIase activity.
11 . The Pin1 polypeptide fragment of claim 10 , wherein the conservative variant amino acid(s) occur at one or more of residues 63-82, 84-96, 98-102, 105, 109, 110, 112, 116, 118, 124, 126, 131-133, 135, 140, 143, 146, 148, 151, 153, 154, and/or 161-163.
12 . The functional fragment of claim 10 , wherein residues 59-62, 83, 97, 103, 104, 106-108, 111, 113-115, 117, 119-123, 125, 127-130, 134, 136-139, 141, 142, 144, 145, 147, 149, 150, 152, and 155-160 of the conservative variant are the identical to the corresponding residue in SEQ ID NO:2.
13 . A functional fragment of a Pin1 polypeptide having a deletion of one or more of amino acid residues 1-58, wherein the functional fragment has PPIase activity, and wherein the Pin1 polypeptide consists of the amino acid sequence set forth in SEQ ID NO:2.
14 . A functional fragment of a Pin1 polypeptide having a deletion of one or more of amino acid residues 1-4 and/or 44-163, wherein the functional fragment has NIMA-binding activity, and wherein the Pin1 polypeptide consists of the amino acid sequence set forth in SEQ ID NO:2.
15 . An isolated Pin1 polypeptide consisting of an amino acid sequence as set forth in SEQ ID NO:2 with conservative variation at one or more of amino acid residues 1-6, 9, 13-20, 21, 22, 25, 28, 30, 31, 33, 35, 36, 38-58, 63-83, 84-97, 98-103, 105, 109, 110, 112, 116, 118, 124, 126, 131-133, 135, 140, 143, 146, 148, 151, 153-154, and/or 161-163, wherein the Pin1 polypeptide has NIMA-binding activity and/or PPIase activity.
16 . A functional fragment of the Pin1 polypeptide of claim 15 , wherein the fragment has NIMA-binding activity and/or PPIase activity.
17 . The functional fragment of the Pin1 polypeptide of claim 15 , wherein the fragment has NIMA-binding activity and PPIase activity.
18 . The functional fragment of claim 15 , wherein the functional fragment has PPIase activity.
19 . The functional fragment of claim 18 , wherein the functional fragment is at least 105 residues in length.
20 . The functional fragment of claim 15 , wherein the functional fragment has NIMA-binding activity.
21 . The functional fragment of claim 20 , wherein the functional fragment is at least 39 residues in length.
22 . An isolated polypeptide consisting of an amino acid sequence as set forth in SEQ ID NO:2 with conservative variation at one or more of amino acid residues 1-58, wherein the polypeptide has PPIase activity.
23 . An isolated polypeptide consisting of an amino acid sequence as set forth in SEQ ID NO:2 with conservative variation at one or more of amino acid residues 1-4 and/or 44-163, wherein the polypeptide has NIMA-binding activity.
24 . An isolated Pin1 polypeptide consisting of:
a WW domain consisting of amino acid residues 5-43 of SEQ ID NO:2, or a functional fragment thereof, wherein the WW domain or functional fragment thereof binds to NIMA; and a PPIase domain having PPIase activity.
25 . An isolated Pin1 polypeptide consisting of:
a PPIase domain consisting of amino acid residues 59-163 of SEQ ID NO:2, or a functional fragment thereof, wherein the PPIase domain or functional fragment thereof has PPIase activity; and a WW domain that binds to NIMA.Join the waitlist — get patent alerts
Track US2007042467A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.